ReviewInternational journal of molecular sciences2021

Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.

Klaus GrossmannPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.